1)- Tania Triantafyllou, Pieter van der Sluis, Richard Skipworth, Bas P L Wijnhoven. The Implementation of Minimally Invasive Surgery in the Treatment of Esophageal Cancer: A Step Toward Better Outcomes?Oncology and therapy. 2022, 10 (2): 337-349
2)- Sophia Z Humphreys, Robert B Geller, Paul Walden. Pegfilgrastim Biosimilars in US Supportive Oncology: A Narrative Review of Administration Options and Economic Considerations to Maximize Patient Benefit.Oncology and therapy. 2022, 10 (2): 351-361
3)- Qiman Zhang, Jin Zheng, Wen Wang, Elyse M Cornett, Alan David Kaye, Ivan Urits, Omar Viswanath, Fei-Long Wei. The Anticancer Effect of Metformin Combined with Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Non-small Cell Lung Cancer Patients with or Without Type 2 Diabetes Mellitus: A Systematic Review and Meta-analysis.Oncology and therapy. 2022, 10 (2): 363-375
5)- Scott Paulson, David Ray, Sharan Aranha, Amy Scales, Yunfei Wang, Eric Liu. Lanreotide Depot to Treat Gastroenteropancreatic Neuroendocrine Tumors in a US Community Oncology Setting: A Prospective, Observational Study.Oncology and therapy. 2022, 10 (2): 463-479
6)- James Convill, Fiona Blackhall, Janelle Yorke, Corrine Faivre-Finn, Fabio Gomes. The Role of Electronic Patient-Reported Outcome Measures in Assessing Smoking Status and Cessation for Patients with Lung Cancer.Oncology and therapy. 2022, 10 (2): 481-491